Leukogene Therapeutics
Mount Pleasant · Founded 2012
About Leukogene Therapeutics
Leukogene Therapeutics is Charleston, SC based oncology focused biotech company, a spin-out from the Medical University of South Carolina (MUSC). Their mission is to deliver innovative immunotherapies for hard-to-treat cancers with emphasis on immunologically “cold” tumors. Leukogene’s MHC class II targeted M2T™ immunotherapy directs and mobilizes the immune system to trigger a robust, tumor antigen specific immune response and eliminate tumor cells. Their lead candidates in acute myeloid leukemia (AML) and pancreatic ductal adenocarcinoma (PDAC) have already demonstrated preclinical proof of concept.
Company Facts
- Founded: 2012
- Legal name: Leukogene Therapeutics, Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Nov 2025)
- Website: leukogene.com
- Phone: (215) 272-5203
Social Profiles
Canonical: https://fsome.com/organization/leukogene-therapeutics-8335412 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.